Physician profile
Jolene Frame
NPI 1154057339
$1,229.93
in general payments reported to CMS, 2019-2025
22 companies · $327 in 2025
The $327 reported for 2025 was more than what 77% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $90.52 · 2023: $448 · 2024: $364 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,113 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.71 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $147.84 | 2023-2025 | Acessa Provu System, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Organon LLC | $134.15 | 2022-2025 | Nexplanon |
| Abbvie INC. | $129.26 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $115.99 | 2023-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $101.07 | 2022-2024 | Gardasil 9, Gardasil |
| Astellas Pharma US INC | $84.68 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $71.38 | 2023-2025 | Slynd |
| Mayne Pharma Commercial LLC | $63.06 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.83 | 2022-2023 | |
| Millicent US INC | $44.39 | 2024-2025 | Intrarosa, Femring |
| Coloplast Corp | $41.03 | 2024 | |
| Dexcom, INC. | $32.89 | 2025 | Dexcom G6 Transmitter |
| Convatec INC. | $28.31 | 2023 | |
| Coopersurgical, INC. | $25.86 | 2023 | Paragard T 380a |
| Smith+Nephew, INC. | $25.11 | 2025 | Pico |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $23.92 | 2024 | |
| Cepheid | $20.64 | 2024 | |
| Ibsa Pharma INC. | $20.48 | 2024 | Tirosint, Licart |
| Medicem INC. | $19.00 | 2023 | |
| Idorsia Pharmaceuticals US INC | $14.83 | 2023 | Quviviq |
| Agile Therapeutics, INC. | $14.82 | 2023 | Twirla |
| Gynesonics, INC. | $14.39 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jolene Frame listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.